Methylation Effects of COV-19 Infection and Vaccinations

Status unconfirmed

Conditions studied: Covid19

In brief

This is a retrospective non-randomized clinical study of 60 patients total to assess the effects of SARS-CoV-2 infection and the SARS-CoV-2 vaccination. This study will have 2 arms evaluating the epigenomes of patients pre and post-exposure to one of the interventions. The first arm of the study will analyze 40 patients' epigenomes whose DNA methylation was examined pre and post SARS-CoV-2 infection. The second arm of this study is analyzing 20 patients' epigenomes whose DNA methylation was examined pre and post-injection of the SARS-CoV-2 vaccine.

Key facts

Study ID

NCT04939155

Run by

TruDiagnostic

People needed

60

Starts

2021-03-10

Expected to finish

2022-03-10

Last updated by the study team

2021-06-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects that are healthy individuals and of any sex, ethnicity, and anyone above the age of 18 years old.

Where it is running

• TruDiagnostic — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.